Conference Report

Confirmed Renowned Speakers

Dr. H. Michael Shepard,
President & CEO, Enosi Life Sciences, USA
Dr. Tom Blundell,
Professor, University of Cambridge, UK
Dr. Ulo Langel,
Professor, Stockholm University, Sweden
Dr. Mats Larsson,
Professor, Department of Physics, Stockholm University, Sweden
Dr. Maria Koufali,
Managing Director, Research and Innovation, Nottingham University Hospitals NHS Trust, UK
Dr. Ferenc Hudecz,
Professor, Department of Organic Chemistry, Eötvös L. University, Hungary
Dr. Sergey Suchkov,
Professor, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Russia
Dr. Jian Yang,
Senior Director, Digital Heath, Eli Lilly and Company, USA
Dr. Yehuda Shoenfeld,
Professor, Sheba Medical Center, Tel-Aviv University, Israel
Dr. Arne Staby,
Scientific VP, CMC Project Management, Biologics, Novo Nordisk A/S, Denmark
Dr. Michael Markert,
Vice President and Global Head of CardioMetabolic Diseases Research, Boehringer Ingelheim, Germany
Dr. Chuang Kee Ong,
Associate Director, Centre of Genomics Research, AstraZeneca UK Limited, UK
Dr. Ved Srivastava,
Vice President of Peptide Chemistry, Intarcia Therapeutics, USA
Dr. Sylvie Pucheu,
Founder and CSO, CILcare, France
Dr. Andreas Seidl,
Chief Operating Officer, Leukocare AG, Germany
Dr. Wilfried Dathe,
External Consultant and Head of Medical Research, Heck Bio-Pharma GmbH, Germany
Dr. Tomoko Mineno,
Professor, Takasaki University of Health and Welfare, Japan
Dr. Richard Denk,
Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland
Dr. Klaus Groschner,
Professor, Chair of Biophysics, Medical University of Graz, Austria
Dr. Yiqun Li,
Head of IT Lilly Biotechnology Center, Eli Lilly and Company, USA
Dr. Joerg Grosse-Onnebrink,
Head, University Children’s Hospital Münster, Germany
Dr. Steve Gardner,
CEO, PrecisionLife Ltd, UK
Dr. Zhenghong Qin,
Professor, Soochow University School of Pharmaceutical Science, China
Dr. Monika Tandon,
Senior Vice President & Head, Glenmark Pharmaceuticals, India
Exhibition and Poster

IDDST-2023 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.

Why Reserve a Booth at IDDST-2023
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall


Exhibition Date:
Set-up date: May 9, 2023
Show dates: May 10-12, 2023
Place: Tokyo, Japan

Analysis of Attendees Last Year
Scenery of Tokyo
Hosting Organizations
World High Technology Society
Dalian Biteomics, Inc.
Supporting Organizations

International Transmembrane Transporter Society

International Society of Digital Medicine

The Asian Society of Natural Products

UK Pharmacogenetics and Stratified Medicine Network

The Czech Pharmaceutical Society 

The National Hospital Pharmacists Association of Romanian

Journal Partner
Media Partner List

© 2003-2023 All rights reserved by BITeomics
Contact Us: Tel:0086-411-84799609,